These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15453262)

  • 1. Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction.
    Bizzozero OA; DeJesus G; Howard TA
    Neurochem Res; 2004 Sep; 29(9):1675-85. PubMed ID: 15453262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath.
    Bizzozero OA; Bixler HA; Davis JD; Espinosa A; Messier AM
    J Neurochem; 2001 Feb; 76(4):1129-41. PubMed ID: 11181833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide reduces the palmitoylation of rat myelin proteolipid protein by an indirect mechanism.
    Bizzozero OA; Bixler H; Parkhani J; Pastuszyn A
    Neurochem Res; 2001 Oct; 26(10):1127-37. PubMed ID: 11700955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Don't just say no: Differential pathways and pharmacological responses to diverse nitric oxide donors.
    Chiesa JJ; Baidanoff FM; Golombek DA
    Biochem Pharmacol; 2018 Oct; 156():1-9. PubMed ID: 30080991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve.
    Garthwaite G; Goodwin DA; Batchelor AM; Leeming K; Garthwaite J
    Neuroscience; 2002; 109(1):145-55. PubMed ID: 11784706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decompaction of CNS myelin leads to a reduction of the conduction velocity of action potentials in optic nerve.
    Gutiérrez R; Boison D; Heinemann U; Stoffel W
    Neurosci Lett; 1995 Aug; 195(2):93-6. PubMed ID: 7478276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal regrowth in the amyelinated optic nerve of the myelin-deficient rat: ultrastructural observations and effects of ganglioside administration.
    Marciano FF; Gocht A; Dentinger MP; Hof L; Csiza CK; Barron KD
    J Comp Neurol; 1990 May; 295(2):219-34. PubMed ID: 2358514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Order-disorder phenomena in myelinated nerve sheaths. VI. The effects of quaking, jimpy and shiverer mutations: an X-ray scattering study of mouse sciatic and optic nerves.
    Mateu L; Luzzati V; Vonasek E; Borgo M; Lachapelle F
    J Mol Biol; 1996 Feb; 256(2):319-29. PubMed ID: 8594199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.
    Redford EJ; Kapoor R; Smith KJ
    Brain; 1997 Dec; 120 ( Pt 12)():2149-57. PubMed ID: 9448570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interactions of nitric oxide donors with rat oxyhemoglobin.
    Tabrizi-Fard MA; Lee WI; Fung HL
    Biochem Pharmacol; 1999 Aug; 58(4):671-4. PubMed ID: 10413305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro.
    Mitrovic B; Ignarro LJ; Montestruque S; Smoll A; Merrill JE
    Neuroscience; 1994 Aug; 61(3):575-85. PubMed ID: 7969931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture.
    Vidwans AS; Kim S; Coffin DO; Wink DA; Hewett SJ
    J Neurochem; 1999 May; 72(5):1843-52. PubMed ID: 10217260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mechanisms of urethral smooth muscle relaxation by several NO donors and nitric oxide.
    García-Pascual A; Costa G; Labadía A; Jimenez E; Triguero D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):80-91. PubMed ID: 10463337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1 alpha protein as a target for S-nitrosation.
    Sumbayev VV; Budde A; Zhou J; Brüne B
    FEBS Lett; 2003 Jan; 535(1-3):106-12. PubMed ID: 12560087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmalogen phospholipids protect internodal myelin from oxidative damage.
    Luoma AM; Kuo F; Cakici O; Crowther MN; Denninger AR; Avila RL; Brites P; Kirschner DA
    Free Radic Biol Med; 2015 Jul; 84():296-310. PubMed ID: 25801291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function.
    Maass DL; White J; Horton JW
    Crit Care Med; 2005 Dec; 33(12):2794-803. PubMed ID: 16352962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats.
    Chen SR; Eisenach JC; Pan HL
    Neuroscience; 2000; 101(3):759-65. PubMed ID: 11113324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of osmolality on PLP-null myelin structure: implications re axon damage.
    Rosenbluth J; Schiff R; Lam P
    Brain Res; 2009 Feb; 1253():191-7. PubMed ID: 19094971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEMSP exerts a myelin-protecting role in the rat optic nerve.
    Mangas A; Vecino E; David Rodríguez F; Geffard M; Coveñas R
    Neurol Res; 2013 Nov; 35(9):903-11. PubMed ID: 23816275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.